Abstract: An aneurysm treatment system can include an occlusive member configured to be positioned within an aneurysm sac, and a distal conduit coupled to the occlusive member and having a first lumen extending therethrough. A proximal conduit has a second lumen extending therethrough and is positioned adjacent the distal conduit so that the first lumen is in fluid communication with the second lumen. A coupler extends between the distal conduit and the proximal conduit. The coupler may be ruptured to permit the proximal conduit and the distal conduit to be separated from one another.

Abstract: A catheter may include an inner liner, at least one support structure over the inner liner, and an outer jacket over the at least one support structure. In some examples, the catheter includes a tip jacket positioned over a distal portion of the outer jacket and extend beyond a distal-most part of the inner liner and a distal-most part of the outer jacket to define a single-layer catheter tip. In some examples, the at least one support structure may include a braid and a coil. The catheter may include a marker band over a distal portion of one of the braid or the coil. The other of the braid or the coil ends proximally of a proximal end of the marker band, such that the catheter includes a location with lower radial and/or flexural stiffness proximal of the marker band.

Abstract: A medical device having a first portion, a second portion, and at least one connector connecting the first and second portion is formed using additive manufacturing. The method includes forming a plurality of layers of a first portion of the medical device, placing a first removable masking plate over the first portion with an opening of the masking plate aligned with a point of the first portion, forming at least one layer of a first connector on the first portion, wherein the first connector is formed in the opening of the removable masking plate, forming a plurality of layers of a second portion of the medical device, wherein a first layer of the plurality of layers of the second portion is formed partially on the first connector and partially on the removable masking plate, and removing the first removable masking plate.

Abstract: A method of making a medical device includes forming a precursor medical device using additive manufacturing. The precursor medical device includes a first portion, a second portion, a first connector, and a second connector. The first connector connects the first portion to the second portion and is configured to remain. The second connector connects the first portion to the second portion and are configured to be removed. The second connector is formed such that the second connector is less ductile than the first portion, the second portion, and the first connector. The precursor medical device is processed to remove the second connector without adversely affecting the first portion, the second portion, and the first connector.

Abstract: A catheter may include an inner liner, at least one support structure over the inner liner, and an outer jacket over the at least one support structure. In some examples, the catheter includes a tip jacket positioned over a distal portion of the outer jacket and extend beyond a distal-most part of the inner liner and a distal-most part of the outer jacket to define a single-layer catheter tip. In some examples, the at least one support structure may include a braid and a coil. The catheter may include a marker band over a distal portion of one of the braid or the coil. The other of the braid or the coil ends proximally of a proximal end of the marker band, such that the catheter includes a location with lower radial and/or flexural stiffness proximal of the marker band.

Abstract: Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.

Abstract: Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.

Abstract: A medical device having a first portion, a second portion, and at least one connector connecting the first and second portion is formed using additive manufacturing. The method includes forming a plurality of layers of a first portion of the medical device, placing a first removable masking plate over the first portion with an opening of the masking plate aligned with a point of the first portion, forming at least one layer of a first connector on the first portion, wherein the first connector is formed in the opening of the removable masking plate, forming a plurality of layers of a second portion of the medical device, wherein a first layer of the plurality of layers of the second portion is formed partially on the first connector and partially on the removable masking plate, and removing the first removable masking plate.

Abstract: A method of making a medical device includes forming a precursor medical device using additive manufacturing. The precursor medical device includes a first portion, a second portion, a first connector, and a second connector. The first connector connects the first portion to the second portion and is configured to remain. The second connector connects the first portion to the second portion and are configured to be removed. The second connector is formed such that the second connector is less ductile than the first portion, the second portion, and the first connector. The precursor medical device is processed to remove the second connector without adversely affecting the first portion, the second portion, and the first connector.

Abstract: A stent that includes a stent body and one or more weld joints, wherein the weld joints include a radiopaque material, and a method of making a stent that includes using a radiopaque filler material in a welding process.

Abstract: A stent that includes a stent body and one or more weld joints, wherein the weld joints include a radiopaque material, and a method of making a stent that includes using a radiopaque filler material in a welding process.

Abstract: A magnesium alloy includes a rare earth element alloy component comprising yttrium, a rare earth element (REE) other than yttrium, and a balance of magnesium. The rare earth element other than yttrium may comprise two or more rare earth elements other than yttrium. The rare earth element other than yttrium may include a heavy rare earth element and a light rare earth element. The alloy may include about 4-10 wt-% yttrium, 0-9 wt-% heavy REE, 0-7 wt-% light REE, 0-7 wt-% zinc, 0-0.7 wt-% zirconium, and a balance of magnesium. The balance of magnesium may be in an amount up to 90 wt-%.

Abstract: Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.

Abstract: A stent that includes a stent body and one or more weld joints, wherein the weld joints include a radiopaque material, and a method of making a stent that includes using a radiopaque filler material in a welding process.

Abstract: A bioerodible stent includes an inner member of a first biocompatible metal, an intermediate member of a second biocompatible metal, and an outer member of a third biocompatible metal. The first biocompatible metal, second biocompatible metal, and third biocompatible member are selected such that galvanic corrosion occurs between the members. A biodegradable polymer coating may surround the members.

Abstract: A method of making a stent includes a three-dimensional printer receiving a dataset corresponding to a three-dimensional precursor stent. The three-dimensional printer forms a precursor stent. The precursor stent comprises a plurality of bands disposed adjacent to each other, wherein each band comprises a plurality of struts connected by a plurality of crowns, and a plurality of connectors connecting each band to an adjacent band. The precursor stent is processed to remove a selected number of the plurality of connectors between adjacent bands such that at least one connector between each set of adjacent bands is removed. In an embodiment, only one connector remains between each adjacent band after the selected number of connectors have been removed.